FATIMA BAZZI: Open Payments
NPI 1629753223 · DEARBORN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 13 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $441 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $161 |
| Alkermes, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Wegovy, ARISTADA, Fabhalta, TRELEGY ELLIPTA, Ozempic.
Industry payments across MI — which companies pay providers there.
